Walleye Capital LLC Takes $6.26 Million Position in Option Care Health, Inc. $OPCH

Key Points

Error: Response status code does not indicate success: 500 (Internal Server Error).

Walleye Capital LLC purchased a new stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 179,219 shares of the company's stock, valued at approximately $6,264,000. Walleye Capital LLC owned 0.11% of Option Care Health at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in OPCH. Fuller & Thaler Asset Management Inc. increased its position in Option Care Health by 30.8% during the 1st quarter. Fuller & Thaler Asset Management Inc. now owns 4,204,481 shares of the company's stock worth $146,947,000 after buying an additional 989,048 shares during the period. Dimensional Fund Advisors LP increased its position in Option Care Health by 17.4% during the 4th quarter. Dimensional Fund Advisors LP now owns 3,988,051 shares of the company's stock worth $92,518,000 after buying an additional 591,042 shares during the period. Northern Trust Corp increased its position in Option Care Health by 11.8% during the 4th quarter. Northern Trust Corp now owns 2,626,478 shares of the company's stock worth $60,934,000 after buying an additional 278,158 shares during the period. Charles Schwab Investment Management Inc. increased its position in Option Care Health by 4.0% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 2,609,705 shares of the company's stock worth $91,209,000 after buying an additional 99,574 shares during the period. Finally, Nuveen LLC bought a new position in Option Care Health during the 1st quarter worth $70,965,000. Institutional investors own 98.05% of the company's stock.

Insider Buying and Selling

In related news, Director Timothy P. Sullivan purchased 20,000 shares of the firm's stock in a transaction that occurred on Thursday, August 21st. The stock was acquired at an average price of $27.51 per share, for a total transaction of $550,200.00. Following the completion of the acquisition, the director owned 49,229 shares of the company's stock, valued at $1,354,289.79. This represents a 68.43% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Harry M. Jansen Kraemer, Jr. acquired 36,000 shares of the business's stock in a transaction on Wednesday, August 20th. The stock was acquired at an average cost of $27.15 per share, for a total transaction of $977,400.00. Following the transaction, the director owned 375,390 shares of the company's stock, valued at approximately $10,191,838.50. The trade was a 10.61% increase in their position. The disclosure for this purchase can be found here. Insiders own 0.64% of the company's stock.

Option Care Health Price Performance

Option Care Health stock traded up $0.16 during midday trading on Thursday, reaching $28.75. The company's stock had a trading volume of 1,777,868 shares, compared to its average volume of 1,850,522. The business has a 50-day moving average price of $29.66 and a 200-day moving average price of $31.67. Option Care Health, Inc. has a 52 week low of $21.39 and a 52 week high of $35.53. The stock has a market cap of $4.67 billion, a PE ratio of 23.00, a price-to-earnings-growth ratio of 1.74 and a beta of 0.79. The company has a current ratio of 1.52, a quick ratio of 1.00 and a debt-to-equity ratio of 0.81.

Option Care Health (NASDAQ:OPCH - Get Free Report) last announced its quarterly earnings results on Wednesday, July 30th. The company reported $0.41 EPS for the quarter, beating analysts' consensus estimates of $0.40 by $0.01. The firm had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.35 billion. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%.The business's revenue for the quarter was up 15.4% on a year-over-year basis. During the same period last year, the firm posted $0.30 earnings per share. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. On average, sell-side analysts predict that Option Care Health, Inc. will post 1.22 EPS for the current year.

Wall Street Analyst Weigh In

OPCH has been the topic of several recent research reports. Barrington Research reiterated an "outperform" rating and set a $38.00 price objective on shares of Option Care Health in a research report on Thursday, July 10th. Citigroup restated an "outperform" rating on shares of Option Care Health in a research report on Thursday, July 31st. JMP Securities raised their price target on Option Care Health from $36.00 to $38.00 and gave the stock a "market outperform" rating in a research report on Thursday, July 31st. Finally, UBS Group upgraded Option Care Health from a "neutral" rating to a "buy" rating and raised their price target for the stock from $38.00 to $40.00 in a research report on Wednesday, April 30th. Eight analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, Option Care Health presently has a consensus rating of "Moderate Buy" and a consensus price target of $35.75.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.